A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Clinical trial NCT05830097 · UNKNOWN

Trial details

NCT number: NCT05830097
Sponsor: Coherent Biopharma (Hefei) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer, Breast Cancer, Lung Cancer of Pancreas Cancer of Esophagus Cancer Colorectal

Start date: 2023-03-14
Primary completion: 2025-06-30
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.